drugset / Trial / NCT04267679
Cannabidiol for Anxiety
NaSingle-groupOpen-labelTreatment
Summary
This pilot trial seeks to investigate the effect of 25 mg full-spectrum CBD soft gel capsules (up to a total dosage of 100mg per day) on individuals with diagnosed anxiety. All participants will take CBD soft gel capsules for 12 weeks, and will be assessed at 6 weeks and 12 weeks post-enrollment using measures of anxiety, sleep and perception of change.
Timeline
- Start
- 2020-03-01
- Primary completion
- 2020-12-01
- Completion
- 2020-12-01
Outcome
Outcome not reported
Stopped: “Stopped due to COVID-19 pandemic.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cannabidiol | Other / unclassified | 25 mg | — |